Nippon Shinyaku Co (TSE:4516) FCF Margin % : -0.91% (As of Dec. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Nippon Shinyaku Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nippon Shinyaku Co's Free Cash Flow for the three months ended in Dec. 2023 was 円-360 Mil. Nippon Shinyaku Co's Revenue for the three months ended in Dec. 2023 was 円39,413 Mil. Therefore, Nippon Shinyaku Co's FCF Margin % for the quarter that ended in Dec. 2023 was -0.91%.

As of today, Nippon Shinyaku Co's current FCF Yield % is 3.73%.

The historical rank and industry rank for Nippon Shinyaku Co's FCF Margin % or its related term are showing as below:

TSE:4516' s FCF Margin % Range Over the Past 10 Years
Min: 2.51 Med: 9.18 Max: 16.74
Current: 7.49

During the past 13 years, the highest FCF Margin % of Nippon Shinyaku Co was 16.74%. The lowest was 2.51%. And the median was 9.18%.

TSE:4516's FCF Margin % is ranked better than
72.22% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.675 vs TSE:4516: 7.49

Nippon Shinyaku Co FCF Margin % Historical Data

The historical data trend for Nippon Shinyaku Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nippon Shinyaku Co FCF Margin % Chart

Nippon Shinyaku Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

12.17

9.36

16.74

9.00

10.02

Nippon Shinyaku Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-3.10	21.47	-4.11	15.26	-0.91

Competitive Comparison of Nippon Shinyaku Co's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Shinyaku Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nippon Shinyaku Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nippon Shinyaku Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Nippon Shinyaku Co's FCF Margin % falls into.

Nippon Shinyaku Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Nippon Shinyaku Co's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	14442	/	144175
	=	10.02 %

Nippon Shinyaku Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-360	/	39413
	=	-0.91 %

Nippon Shinyaku Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Nippon Shinyaku Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nippon Shinyaku Co (TSE:4516) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nippon Shinyaku Co Ltd (TSE:4516) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

NPPNY:USA

Address

14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, JPN, 601-8550

Website

http://www.nippon-shinyaku.co.jp

Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Nippon Shinyaku Co (TSE:4516) Headlines

No Headlines